Vaccinating pregnant women against RSV reduced the risk of infection in their infants by 61% compared with newborns with ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

RSV is a contagious virus causing severe respiratory infections in infants. Vaccination during pregnancy, provides newborns ...

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

“The availability of two different RSV protection methods in sufficient supply may have ... Several authors disclosed ties to pharmaceutical companies, including Pfizer, which manufactures the RSVpreF ...

In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...